Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Immune Crosstalk Profiling of Non-Hodgkin Lymphoma (NHL) Tumor Immune Microenvironment Identifies Two Clusters Based on T Cell Exhaustion, Correlating with Different Clinical Outcomes

Daniel Medina, Laura Palomo, Víctor Navarro, Cristina García, Juan Camilo Nieto, Júlia Carabia, Carlota Pagès Geli, Pamela Acha, Gemma Pujadas, Carlos Palacio, Laura Gallur, Josep Castellvi, Pau Abrisqueta, Francesc Bosch, Marta Crespo

Blood (2024) 144 (Supplement 1): 6251.

https://doi.org/10.1182/blood-2024-205108

Published: 2024

Journal Articles

Ibromics: A Real-World Study of Clinical and Biological Parameters in Patients with Chronic Lymphocytic Leukemia (CLL) Treated in First Line with Single Agent Ibrutinib

Cecilia Muñoz-Calleja, José Ángel Hernández-Rivas, Francesc Bosch, Laura Palomo, Adrian Mosquera Orgueira, Angel Ramirez, Ruben Fernandez Alvarez, Ana C Oliveira, Paula Amat Martinez, Alicia Serrano, Aránzazu García-Grande, Ana Yeguas, Marta Crespo, Miguel Alcoceba, Blanca Ferrer Lores, José Antonio Garcia Vela, Luis Espinosa-Hevia, Celia Bolumburu, Miguel Villanueva Forero

Blood (2024) 144 (Supplement 1): 6769.

https://doi.org/10.1182/blood-2024-199097

Published: 2024

Journal Articles

Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target

Daniel Medina, Laura Palomo, Víctor Navarro, Oriol Castells, Belén Sánchez, Pau Marc Muñoz Torres, Carlota Pagès Geli, Cristina Hernández, Gemma Pujadas, Alba Cabirta Touzón, Christelle Ferrà, Miguel Alcoceba, María José Terol, Rafael Andreu, Francesc Bosch, Pau Abrisqueta, Marta Crespo

Blood (2023) 142 (Supplement 1): 3254.

https://doi.org/10.1182/blood-2023-185683

Published: 2023

Journal Articles

Macrophages Play a Key Role in Controlling Tumor Growth and Response to Immunotherapy in Primary Central Nervous System Lymphoma

Carlota Pages-Geli, Daniel Medina, Cristina Hernandez, Patricia Fernandez, Gemma Pujadas, Francesc Bosch, Marta Crespo

Blood (2023) 142 (Supplement 1): 1642.

https://doi.org/10.1182/blood-2023-180719

Published: 2023

Journal Articles

Deciphering Transcriptomic and (Epi)Genetic Signatures of Central Nervous System Infiltration in Patients Diagnosed with Diffuse Large B-Cell Lymphoma

Carlota Pages-Geli, Sabela Bobillo, Pau Abrisqueta, Josep Castellvi, Laura Palomo, Damiana Alvarez, Manel Esteller, Francesc Bosch, Marta Crespo

Blood (2023) 142 (Supplement 1): 1618.

https://doi.org/10.1182/blood-2023-174653

Published: 2023

Journal Articles

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Blood (2023) 142 (Supplement 1): 3927.

https://doi.org/10.1182/blood-2023-191146

Published: 2023

Journal Articles

Resistance Mechanisms Impacting Bispecific Antibody (BsAbs) and Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcomes in Large B Cell Lymphoma (LBCL) Patients

Blood (2023) 142 (Supplement 1): 1635.

https://doi.org/10.1182/blood-2023-186072

Published: 2023

Journal Articles

Clinical Impact of Sars-Cov-2 Vaccination in COVID-19 Outcomes in Patients Diagnosed with Hematologic Malignancies: Real-World Evidence of Two Years of Pandemic

Blood (2022) 140 (Supplement 1): 2628–2630.

https://doi.org/10.1182/blood-2022-169321

Published: 2022

Journal Articles

Epidemiological Characterization and Determination of TP53 and IGHV Mutational Status of a Large Series of Previously-Untreated Chronic Lymphocytic Leukemia (CLL) Patients in Spain: The Epicll Study

María José Terol, Alicia Serrano, Blanca Ferrer Lores, Francesc Bosch, Marcos Gonzalez Diaz, Marta Crespo, Miguel Alcoceba, Azahara Fuentes, Javier F Chaves, Lucia Esteve, Cristina Loriente, Miguel Villanueva

Blood (2021) 138 (Supplement 1): 1564.

https://doi.org/10.1182/blood-2021-150278

Published: 2021

Journal Articles

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

Blood (2021) 137 (16): 2267–2271.

https://doi.org/10.1182/blood.2020008609

Published: 2021

Includes: Supplemental data

Journal Articles

Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab

Juan C Nieto, PhD, Elisa Roldan, MD, Isabel Jiménez, MSc, Laura Fox, Júlia Carabia, PhD, Guillermo Orti, Lluis Puigdefàbregas, Laura Gallur, Gloria Iacoboni, MD, Priyanka Raheja, Ana Perez, Olga Salamero, MD, Carlos Palacio, David Valcarcel, MD, Marta Crespo, PhD, Francesc Bosch, MD, Pere Barba, MD

Blood (2018) 132 (Supplement 1): 3402.

https://doi.org/10.1182/blood-2018-99-114887

Published: 2018

Journal Articles

Xpo-1 Inhibition Synergizes with BCR Inhibition, Blocks Tumor Growth and Tumor-Associated Macrophages Infiltration and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Marta Crespo, PhD, Júlia Carabia, MSc, Isabel Jiménez, MSc, Sabela Bobillo, MD, Pau Abrisqueta, MD PhD, Carles Palacio, MD, Juan C Nieto, PhD, Joan Boix, BSc, Cecilia Carpio, MD, Josep Castellvi, Joan Seoane, Francesc Bosch

Blood (2017) 130 (Supplement 1): 2808.

https://doi.org/10.1182/blood.V130.Suppl_1.2808.2808

Published: 2017

Journal Articles

Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells

Isabel Jiménez, MSc, Sabela Bobillo, MD, Pau Abrisqueta, MD PhD, Bárbara Tazón, PhD, Carles Palacio, MD, Juan C Nieto, PhD, Júlia Carabia, MSc, Maria Jose Terol, MD PhD, Jose Garcia-Marco, MD PhD, Joan Boix, BSc, Magdalena Munuera, BSc, Lluis Puigdefàbregas, Elisa Roldán, Marta Crespo, PhD, Francesc Bosch

Blood (2017) 130 (Supplement 1): 1713.

https://doi.org/10.1182/blood.V130.Suppl_1.1713.1713

Published: 2017

Journal Articles

XPO1 Inhibition By Selinexor Synergizes with BCR Inhibition, Blocks Tumor Growth and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Marta Crespo, Julia Carabia, Isabel Jiménez, Sabela Bobillo, Pau Abrisqueta, Carles Palacio, Cecilia Carpio, MD, Josep Castellvi, Noelia Purroy, Joan Seoane, Francesc Bosch, MD PhD

Blood (2016) 128 (22): 463.

https://doi.org/10.1182/blood.V128.22.463.463

Published: 2016

Journal Articles

Syk Inhibition By TAK-659 Overcomes Proliferative, Survival and Migratory Signals from the Microenvironment in Chronic Lymphocytic Leukemia Cells

Noelia Purroy, MD, Pau Abrisqueta, MD, Júlia Carabia, Eva Calpe, PhD, Cecilia Carpio, MD, Carles Palacio, MD, Marta Crespo, PhD, Francesc Bosch, MD PhD

Blood (2014) 124 (21): 4698.

https://doi.org/10.1182/blood.V124.21.4698.4698

Published: 2014

Journal Articles

Microrna Mir-21 Is Upregulated after Different Microenvironmental Stimuli and Controls Proliferation, Chemotaxis and Chemoresistance in Chronic Lymphocytic Leukemia

Marta Crespo, PhD, Júlia Carabia, Noelia Purroy, MD, Cecilia Carpio, MD, Pau Abrisqueta, MD, Carles Palacio, MD, Francesc Bosch, MD PhD

Blood (2014) 124 (21): 1971.

https://doi.org/10.1182/blood.V124.21.1971.1971

Published: 2014

Journal Articles

Regulation Of Microrna Mir-21 Expression By ZAP-70 Protein In Chronic Lymphocytic Leukemia

Marta Crespo, PhD, Cecilia Carpio, MD, Júlia Carabia, Pau Abrisqueta, MD, Eva Calpe, Noelia Purroy, MD, Carles Palacio, MD, Francesc Bosch, MD, PhD

Blood (2013) 122 (21): 4145.

https://doi.org/10.1182/blood.V122.21.4145.4145

Published: 2013

Journal Articles

The Co-Culture Of Primary CLL Cells With Bone Marrow Mesenchymal Cells, CD40 Ligand and CpG ODN Promotes The Proliferation Of Chemoresistant CLL Cells Phenotypically Comparable To Those From The Proliferative Centers

Noelia Purroy, MD, Pau Abrisqueta, MD, Eva Calpe, Cecilia Carpio, MD, Carles Palacio, MD, Laura Gallur, MD, Marta Crespo, PhD, Francesc Bosch, MD, PhD

Blood (2013) 122 (21): 4153.

https://doi.org/10.1182/blood.V122.21.4153.4153

Published: 2013

Journal Articles

ZAP-70 Enhances Infiltration of Malignant B Lymphocytes Into the Bone Marrow by Increasing Migratory and Survival Responses to CXCR4 Stimulation

Marta Crespo, PhD, Eva Calpe, Noelia Purroy, MD, Cecilia Carpio, MD, Pau Abrisqueta, MD, Carles Palacio, MD, Josep Castellvi, MD, Francesc Bosch, MD, PhD

Blood (2012) 120 (21): 1779.

https://doi.org/10.1182/blood.V120.21.1779.1779

Published: 2012

Journal Articles

YM155, a Small-Molecule Survivin Suppressant, Mainly Targets Primary CLL Cells Actively Proliferating and Overcomes Microenvironment-Mediated CLL Cell Protection

Noelia Purroy, MD, Pau Abrisqueta, MD, Eva Calpe, Cecilia Carpio, MD, Carles Palacio, MD, Laura Gallur, MD, Marta Crespo, PhD, Francesc Bosch, MD, PhD

Blood (2012) 120 (21): 3868.

https://doi.org/10.1182/blood.V120.21.3868.3868

Published: 2012

NARROW

Immune Crosstalk Profiling of Non-Hodgkin Lymphoma (NHL) Tumor Immune Microenvironment Identifies Two Clusters Based on T Cell Exhaustion, Correlating with Different Clinical Outcomes

Ibromics: A Real-World Study of Clinical and Biological Parameters in Patients with Chronic Lymphocytic Leukemia (CLL) Treated in First Line with Single Agent Ibrutinib

Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target

Macrophages Play a Key Role in Controlling Tumor Growth and Response to Immunotherapy in Primary Central Nervous System Lymphoma

Deciphering Transcriptomic and (Epi)Genetic Signatures of Central Nervous System Infiltration in Patients Diagnosed with Diffuse Large B-Cell Lymphoma

Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies

Resistance Mechanisms Impacting Bispecific Antibody (BsAbs) and Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcomes in Large B Cell Lymphoma (LBCL) Patients

Clinical Impact of Sars-Cov-2 Vaccination in COVID-19 Outcomes in Patients Diagnosed with Hematologic Malignancies: Real-World Evidence of Two Years of Pandemic

Epidemiological Characterization and Determination of TP53 and IGHV Mutational Status of a Large Series of Previously-Untreated Chronic Lymphocytic Leukemia (CLL) Patients in Spain: The Epicll Study

B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide

Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab

Xpo-1 Inhibition Synergizes with BCR Inhibition, Blocks Tumor Growth and Tumor-Associated Macrophages Infiltration and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells

XPO1 Inhibition By Selinexor Synergizes with BCR Inhibition, Blocks Tumor Growth and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma

Syk Inhibition By TAK-659 Overcomes Proliferative, Survival and Migratory Signals from the Microenvironment in Chronic Lymphocytic Leukemia Cells

Microrna Mir-21 Is Upregulated after Different Microenvironmental Stimuli and Controls Proliferation, Chemotaxis and Chemoresistance in Chronic Lymphocytic Leukemia

Regulation Of Microrna Mir-21 Expression By ZAP-70 Protein In Chronic Lymphocytic Leukemia

The Co-Culture Of Primary CLL Cells With Bone Marrow Mesenchymal Cells, CD40 Ligand and CpG ODN Promotes The Proliferation Of Chemoresistant CLL Cells Phenotypically Comparable To Those From The Proliferative Centers

ZAP-70 Enhances Infiltration of Malignant B Lymphocytes Into the Bone Marrow by Increasing Migratory and Survival Responses to CXCR4 Stimulation

YM155, a Small-Molecule Survivin Suppressant, Mainly Targets Primary CLL Cells Actively Proliferating and Overcomes Microenvironment-Mediated CLL Cell Protection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only